RxDoctor Payments Data

Carolyn Borne, PA

Medical · Terrytown, LANPI 1053694273

Payments from drug & device makers

$2,502in general payments, 2019–2025

Across 132 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$461
  • Takeda Pharmaceuticals U.S.A., Inc.$424
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$421
  • Ardelyx, Inc.$170
  • Johnson & Johnson$155
  • Gilead$123
  • plus $747 from 19 others

What the payments were for

  • Food & beverage$2,502100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,502 in reported general payments places this provider in the 70th percentile of 253 medical providers in Louisiana.

See all medical providers in Louisiana

Medicare billing

Part B allowed, 2024
$23,234
Medicare patients
196
Services billed
240

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide66$52,023
ClenpiqSod Picosulf/Mag Ox/Citric Ac60$9,536
Dexlansoprazole DrDexlansoprazole24$5,846
Pantoprazole Sodium336$4,692
Mesalamine11$2,705
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C16$2,123
Esomeprazole Magnesium36$1,446
Omeprazole78$876
Sucralfate17$770
Budesonide DrBudesonide14$766
Famotidine40$423
Imipramine Hcl11$182
Dicyclomine Hcl19$152
Amitriptyline Hcl19$145
Ondansetron OdtOndansetron12$114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$461$52,02366 claims
Ferring Pharmaceuticals Inc.Clenpiq$55$9,53660 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu$421$2,12316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 253 medical providers in Louisiana.

Other medical in Terrytown

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →